The in vitro diagnostics (IVD) market, already valued at USD $102 billion in 2024, is on the brink of transformation, driven by the surge in liquid biopsy technologies.

SCIENCE MADE SIMPLE
Stay Updated! Subscribe to The Primer
Share
The in vitro diagnostics (IVD) market, already valued at USD $102 billion in 2024, is on the brink of transformation, driven by the surge in liquid biopsy technologies.
Discover groundbreaking treatments and technological advancements for migraine relief. Find out how these new standards are changing patient expectations.
Digital health technologies, including AI, mHealth apps, wearables, and telehealth, are revolutionizing healthcare, making wellness more accessible, efficient, and affordable.
A breath biopsy is a diagnostic method that analyzes the volatile organic compounds (VOCs) in a person’s breath to detect diseases.
Cancer diagnoses usually require a surgical biopsy. Liquid biopsies offer a simpler and less painful alternative.
Covid-19 accelerated the adoption of telehealth with 40% market penetration – Discover more about the software & healthcare digital transformation.
Biotech Primer is your go-to source for interactive training across the biotechnology, pharmaceutical, molecular diagnostics, and medical device sectors. Explore a range of in-depth biotech courses designed to deepen your understanding of key principles and applications in the field.